---
title: "Suzhou Wangshan Wangshui Biomedicine Co., Ltd. plans to price its Hong Kong IPO at HKD 33.37 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264129175.md"
description: "According to reports, Suzhou Wangshan Wangshui Biomedicine Co., Ltd. plans to price its Hong Kong IPO at HKD 33.37 per share. (Sina Finance)"
datetime: "2025-11-04T03:16:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264129175.md)
  - [en](https://longbridge.com/en/news/264129175.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264129175.md)
generator: "portal-rs"
---

# Suzhou Wangshan Wangshui Biomedicine Co., Ltd. plans to price its Hong Kong IPO at HKD 33.37 per share

According to reports, Suzhou Wangshan Wangshui Biomedicine Co., Ltd. plans to price its Hong Kong IPO at HKD 33.37 per share. (Sina Finance)

### Related Stocks

- [399441.CN](https://longbridge.com/en/quote/399441.CN.md)

## Related News & Research

- [Pondy Oxides And Chemicals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected](https://longbridge.com/en/news/305560101.md)
- [Alkem Laboratories Limited (NSE:ALKEM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/305559747.md)
- [RioCan Real Estate Investment Trust (TSX:REI.UN) Expands Its Buyback Program, Is It Still Undervalued?](https://longbridge.com/en/news/305557624.md)
- [Kava Lend loses roughly $3.8 million to hack, sending KAVA token down nearly 40%](https://longbridge.com/en/news/305556359.md)
- [HONGQI EHS4 Set for Global Debut in Venice: Eastern Elegance Arrives in Europe](https://longbridge.com/en/news/305555184.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**